NDC Crossover 61755-921 Alirocumab

View and Compare Similar Products, Alternatives & Options

NDC Crossover of Similar Products Matching Alirocumab

The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.

Explore similar products to 61755-921 – Alirocumab, drug for further processing. This list includes other cross-matching products that share:

The same product name: Alirocumab
OR Generic name: Alirocumab
AND the same Administration Route:
OR Dosage Form: injection, solution

This list of related drugs for easy comparison is ideal for healthcare professionals, pharmacists, and patients looking for alternative or substitute products.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Product Type
0024-5901	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
0024-5902	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Sanofi-aventis U.s. Llc	Human Prescription Drug
61755-020	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Regeneron Pharmaceuticals, Inc.	Human Prescription Drug
61755-021	Praluent	Alirocumab	Injection, Solution	Subcutaneous	Regeneron Pharmaceuticals, Inc.	Human Prescription Drug